secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001104659-22-056448
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience Q2 revenue $48.1M (+54% YoY), orders $55.0M (+32% YoY)
-----------------------------------------------------------------------

- Record revenue $48.1M, up 54% YoY from $31.2M.
- Net loss $60.7M ($1.13/share) vs $37.9M ($0.78) prior year.
- Orders $55.0M, up 32% YoY from $41.7M.
- Four-year supply agreement with Ginkgo Bioworks, $58M minimum purchases over contract term.
- Cash $604.4M; raised $269.8M net from public offering completed in the quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922056448/0001104659-22-056448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922056448/tm2214535d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-056448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer